ArticleMalaria journal2025
Adherence to the test, treat and track malaria policy among selected health facilities in Ghana: the clients' perspective.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundMalaria continues to be a major disease burden affecting all ages. The WHO in 2012 introduced the test, treat and track (T3) policy for malaria management in endemic settings. All malaria suspected conditions are to be confirmed by test and treatment initiated with recommended artemisinin-based combination therapy (ACT) and treatment outcomes monitored over the course of the illness. This study evaluated the adherence of health facilities and client's perspective of T3 policy in Ghana.
methodsThis cross sectional study was conducted in November 2019 involving 30 health facilities conveniently selected from six districts in the 3 malaria epidemiological zones, and clients exit interviews were performed from each facility. Factors associated with the test, treat and track defined outcomes were assessed using chi square and multivariable logistic regression models at 5% level of significance and 95% confidence interval. Data were classified according to facility and clients' perspectives.
resultsOverall, 590 patients and 30 health facility managers were interviewed from 30 facilities in 6 districts across the three zones. CHPS compounds formed 18 (60.0%) of facilities assessed. Twenty-nine out of 30 health facilities had Rapid Diagnostic Test (RDT) kits and antimalarials. Health facilities in the southern zone of Ghana had 2.87 increased odds of adhering to the T3 policy compared to the middle zone [aOR = 2.87 (1.7, 4.8): p < 0.001]. Males were more likely not to return to the health facility for review or more likely to miss home visit [aOR = 0.6 (0.3, 0.9): p = 0.018].
conclusionTesting and treating for malaria were high among health facilities in the three zones. However, tracking of patients was very low across the zones. Adherence from clients' perspective was low especially for males. The study recommended among others that the National Malaria Elimination Programme (NMEP) should ensure periodic trainings of health facility staff especially those within the Northern and Middle zones of Ghana and strengthen monitoring and supervision of health facilities to enhance adherence to the T3 policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.